Quantification of individual remyelination during short-term disease course by synthetic magnetic resonance imaging

MRI is an important diagnostic tool for evaluation of myelin content in multiple sclerosis and other CNS diseases, being especially relevant for studies investigating remyelinating pharmacotherapies. In this study, we evaluated a new synthetic MRI–based myelin estimation in methylenetetrahydrofolate...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Ruth, Matusche, Britta, Ladopoulos, Theodoros, Ayzenberg, Ilya, Biesalski, Anne Sophie, Gold, Ralf, Bellenberg, Barbara, Lukas, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351729/
https://www.ncbi.nlm.nih.gov/pubmed/35938071
http://dx.doi.org/10.1093/braincomms/fcac172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351729/
https://www.ncbi.nlm.nih.gov/pubmed/35938071
http://dx.doi.org/10.1093/braincomms/fcac172

Ejemplares similares